DK1631373T3 - Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse - Google Patents
Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelseInfo
- Publication number
- DK1631373T3 DK1631373T3 DK04735882T DK04735882T DK1631373T3 DK 1631373 T3 DK1631373 T3 DK 1631373T3 DK 04735882 T DK04735882 T DK 04735882T DK 04735882 T DK04735882 T DK 04735882T DK 1631373 T3 DK1631373 T3 DK 1631373T3
- Authority
- DK
- Denmark
- Prior art keywords
- micropellets
- formulations
- preparation
- active material
- fluidized bed
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/16—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Glanulating (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10325989A DE10325989A1 (de) | 2003-06-07 | 2003-06-07 | Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung |
PCT/EP2004/005993 WO2004108266A1 (de) | 2003-06-07 | 2004-06-03 | Mikropellets, verfahren zur ihrer herstellung sowie deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1631373T3 true DK1631373T3 (da) | 2009-04-14 |
Family
ID=33494906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04735882T DK1631373T3 (da) | 2003-06-07 | 2004-06-03 | Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060115539A1 (da) |
EP (1) | EP1631373B1 (da) |
JP (1) | JP2006527223A (da) |
AT (1) | ATE418383T1 (da) |
DE (2) | DE10325989A1 (da) |
DK (1) | DK1631373T3 (da) |
ES (1) | ES2318295T3 (da) |
PT (1) | PT1631373E (da) |
WO (1) | WO2004108266A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
JP2007513146A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 液体系プロセスによるアジスロマイシンマルチパーティキュレート剤形 |
KR20120091378A (ko) | 2004-03-23 | 2012-08-17 | 노파르티스 아게 | 제약 조성물 |
DE102005047561A1 (de) * | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
DE102006001554A1 (de) * | 2006-01-05 | 2007-07-12 | Ipc Process-Center Gmbh & Co. | Micropellets für die Herstellung von Tiernahrungspellets |
JP5141115B2 (ja) * | 2006-07-11 | 2013-02-13 | 大正製薬株式会社 | 不快味を呈する薬物含有製剤粒子 |
CA2669938C (en) * | 2006-11-15 | 2016-01-05 | Abbott Laboratories | Solid pharmaceutical dosage formulations |
AU2008214199A1 (en) * | 2007-02-09 | 2008-08-14 | Poniard Pharmaceuticals, Inc. | Encapsulated picoplatin |
DK2868315T3 (da) | 2007-12-04 | 2017-09-04 | Biogen Chesapeake Llc | Forbedrede formuleringer og fremgangsmåder til frysetørring og derved fremstillede lyofilater |
DE102008004893A1 (de) * | 2008-01-17 | 2009-07-23 | Add Technologies Ltd. | Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung |
DE102008037025C5 (de) | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
EP2599477A1 (en) | 2011-11-30 | 2013-06-05 | Lunamed AG | 4-Phenylbutyric acid sustained release formulation |
EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
EP3717550A2 (en) * | 2017-12-01 | 2020-10-07 | Cable Components Group LLC | Foamable compositions and methods for fabricating foamed articles |
US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
CN117413659B (zh) * | 2023-12-19 | 2024-04-19 | 蒙草生态环境(集团)股份有限公司 | 一种实验室用种子包衣丸化装置 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163836B1 (de) * | 1984-04-07 | 1988-10-12 | Bayer Ag | Verfahren und Vorrichtung zur Herstellung von Granulaten |
US4835188A (en) * | 1987-12-08 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
IL88961A (en) * | 1988-01-29 | 1992-07-15 | Basf Ag | Stable mixtures containing oxidation-sensitive compounds |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
DE19514187C1 (de) * | 1995-04-21 | 1996-05-15 | Degussa | Verfahren und Vorrichtung zur Herstellung von Granulaten durch Wirbelschicht-Sprühgranulation |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
ES2310164T3 (es) * | 1999-02-10 | 2009-01-01 | Pfizer Products Inc. | Dispositivo de liberacion controlada por la matriz. |
US6264983B1 (en) * | 1999-09-16 | 2001-07-24 | Rhodia, Inc. | Directly compressible, ultra fine acetaminophen compositions and process for producing same |
SE0100822D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method II to obtain microparticles |
AR033711A1 (es) * | 2001-05-09 | 2004-01-07 | Novartis Ag | Composiciones farmaceuticas |
CA2445606A1 (en) * | 2001-05-11 | 2002-11-21 | Pacific Pharmaceuticals Limited | Taste masking pharmaceutical composition |
JP4833464B2 (ja) * | 2001-11-28 | 2011-12-07 | 大正製薬株式会社 | 難溶性薬物含有固形製剤の製造方法 |
-
2003
- 2003-06-07 DE DE10325989A patent/DE10325989A1/de not_active Withdrawn
-
2004
- 2004-06-03 DK DK04735882T patent/DK1631373T3/da active
- 2004-06-03 US US10/559,882 patent/US20060115539A1/en not_active Abandoned
- 2004-06-03 WO PCT/EP2004/005993 patent/WO2004108266A1/de active Application Filing
- 2004-06-03 DE DE502004008734T patent/DE502004008734D1/de not_active Expired - Lifetime
- 2004-06-03 ES ES04735882T patent/ES2318295T3/es not_active Expired - Lifetime
- 2004-06-03 JP JP2006515825A patent/JP2006527223A/ja active Pending
- 2004-06-03 AT AT04735882T patent/ATE418383T1/de active
- 2004-06-03 EP EP04735882A patent/EP1631373B1/de not_active Expired - Lifetime
- 2004-06-03 PT PT04735882T patent/PT1631373E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EP1631373B1 (de) | 2008-12-24 |
JP2006527223A (ja) | 2006-11-30 |
DE10325989A1 (de) | 2005-01-05 |
ES2318295T3 (es) | 2009-05-01 |
ATE418383T1 (de) | 2009-01-15 |
EP1631373A1 (de) | 2006-03-08 |
WO2004108266A1 (de) | 2004-12-16 |
PT1631373E (pt) | 2009-02-16 |
DE502004008734D1 (de) | 2009-02-05 |
US20060115539A1 (en) | 2006-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1631373T3 (da) | Mikropellets, fremgangsmåde til fremstilling af disse samt deres anvendelse | |
WO2017049245A3 (en) | Compounds and compositions for intracellular delivery of therapeutic agents | |
MX2007016021A (es) | Particulas que tienen material hidrofobico en estas. | |
WO2001032830A3 (en) | Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | |
HK1087133A1 (en) | Method for producing aqueous dispersions | |
WO2003043631A3 (en) | Method for identification of tumor targeting enzymes | |
WO2007049156A3 (en) | I-CreI HOMING ENDONUCLEASE VARIANTS HAVING NOVEL CLEAVAGE SPECIFICITY AND USE THEREOF | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2007059008A3 (en) | N-substituted indenoisoquinolines and syntheses thereof | |
WO2006027521A3 (fr) | Procede d'obtention d'un principe actif raffermissant et ledit actif | |
MY149422A (en) | 5-(arylsulfonyl)-pyrazolopiperidines | |
WO2007067828A3 (en) | Glp-2 mimetibodies, polypeptides, compositions, methods and uses | |
WO2006055532A3 (en) | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof | |
MXPA05007792A (es) | Prodrogas de propofol derivadas de aminoacido, composiciones y usos de las mismas. | |
WO2009098682A3 (en) | Methods and compositions for treatment of mitochondrial disorders | |
WO2007040574A3 (en) | Biomimetic nanocomposite | |
WO2002036742A3 (en) | Method for chemical transformation using a mutated enzyme | |
BRPI0407181A (pt) | Formulação farmacêutica | |
WO2006009733A3 (en) | Frozen tissue microarray | |
WO2005007117A3 (en) | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders | |
WO2001083774A3 (en) | Novel mutated form of arginine deiminase | |
ATE468398T1 (de) | Herstellungsverfahren zur produktion aktiver und löslicher proteine in prokaryonten und polycistronische vektoren dafür | |
WO2003099202A3 (en) | Beta-secretase inhibitors | |
WO2012047037A3 (ko) | 배아줄기세포 유래 심근세포 및 이를 유효성분으로 포함하는 세포치료제 | |
WO2004083362A3 (en) | Modification of subtilases using protein modelling based on the jp170 three-dimensional structure |